Shedir Pharma Srl Unipersonale
MIL:SHE
Shedir Pharma Srl Unipersonale
MIL:SHE
Price:
4.88
EUR
Market Closed
Market Cap:
€55.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shedir Pharma Srl Unipersonale
MIL:SHE
|
IT |
|
O'Key Group SA
LSE:OKEY
|
LU |
|
H
|
Heiwa Real Estate Co Ltd
TSE:8803
|
JP |
|
S
|
Samsung Electronics Co Ltd
SWB:SSUN
|
KR |
|
D
|
Deciphera Pharmaceuticals Inc
F:D05
|
US |
|
Zett Corp
TSE:8135
|
JP |
|
Oryzon Genomics SA
MAD:ORY
|
ES |
|
G
|
Guangdong Huate Gas Co Ltd
SSE:688268
|
CN |
|
Interlife Holdings Co Ltd
TSE:1418
|
JP |
|
Maintel Holdings PLC
LSE:MAI
|
UK |
|
Thomson Reuters Corp
TSX:TRI
|
CA |
|
Loras Holding AS
IST:LRSHO.E
|
TR |
|
Cannamerica Brands Corp
OTC:CNNXF
|
CA |
Cash Flow Statement
Cash Flow Statement
Shedir Pharma Srl Unipersonale
Shedir Pharma Srl Unipersonale
Currency: EUR
| Mar-2019 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
0
|
8
|
5
|
4
|
5
|
4
|
6
|
6
|
8
|
9
|
8
|
9
|
|
| Depreciation & Amortization |
0
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
|
| Other Non-Cash Items |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
0
|
1
|
2
|
0
|
1
|
2
|
2
|
1
|
2
|
3
|
2
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
2
|
(4)
|
(10)
|
(3)
|
2
|
1
|
3
|
2
|
(8)
|
(12)
|
(12)
|
(3)
|
|
| Cash from Operating Activities |
2
N/A
|
(0)
N/A
|
(3)
-1 464%
|
3
N/A
|
10
+187%
|
9
-14%
|
12
+37%
|
11
-5%
|
3
-78%
|
0
-85%
|
1
+60%
|
9
+1 464%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(2)
|
(4)
|
(2)
|
|
| Other Items |
(1)
|
(1)
|
7
|
7
|
(1)
|
(1)
|
(4)
|
(3)
|
(2)
|
(8)
|
(8)
|
(2)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-14%
|
7
N/A
|
7
+1%
|
(1)
N/A
|
(1)
-45%
|
(5)
-246%
|
(4)
+14%
|
(3)
+33%
|
(10)
-245%
|
(11)
-17%
|
(5)
+59%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Debt |
0
|
0
|
(0)
|
(1)
|
1
|
(0)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(3)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
(2)
|
0
|
(2)
|
(2)
|
0
|
|
| Other |
(2)
|
(2)
|
(1)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
(2)
N/A
|
1
N/A
|
(1)
N/A
|
(3)
-247%
|
1
N/A
|
(3)
N/A
|
(4)
-58%
|
(3)
+41%
|
(3)
-18%
|
(3)
+8%
|
(4)
-40%
|
(4)
+10%
|
|
| Change in Cash | |||||||||||||
| Net Change in Cash |
(1)
N/A
|
0
N/A
|
3
+7 402%
|
7
+136%
|
10
+39%
|
4
-57%
|
3
-41%
|
5
+72%
|
(3)
N/A
|
(12)
-262%
|
(15)
-22%
|
1
N/A
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
2
N/A
|
(1)
N/A
|
(3)
-417%
|
3
N/A
|
10
+228%
|
8
-16%
|
11
+33%
|
10
-2%
|
2
-80%
|
(2)
N/A
|
(3)
-96%
|
7
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
